|
|
|
|
| LEADER |
03393nmm a2200877 u 4500 |
| 001 |
EB002165620 |
| 003 |
EBX01000000000000001303399 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841216440
|
| 050 |
|
4 |
|a TP1180.P653
|
| 100 |
1 |
|
|a Harris, J. Milton
|e [editor]
|
| 245 |
0 |
0 |
|a Poly(ethylene glycol)
|b chemistry and biological applications
|c J. Milton Harris, editor, Samuel Zalipsky, editor
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 1997, 1997
|
| 300 |
|
|
|a 508 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Hydrazine / Analysis
|
| 653 |
|
|
|a Peptides / chemical synthesis
|
| 653 |
|
|
|a Liposomes
|
| 653 |
|
|
|a Enzymology
|
| 653 |
|
|
|a Drug delivery systems
|
| 653 |
|
|
|a Polyethylene glycol
|
| 653 |
|
|
|a Cytokines / Analysis
|
| 653 |
|
|
|a Ocular pharmacology
|
| 653 |
|
|
|a Polymers / Conformation
|
| 653 |
|
|
|a Oligonucleotides
|
| 653 |
|
|
|a Proteins / pharmacokinetics
|
| 653 |
|
|
|a Epoxy Compounds / chemical synthesis
|
| 653 |
|
|
|a Combinatorial chemistry
|
| 653 |
|
|
|a Doxorubicin / analysis
|
| 653 |
|
|
|a Doxorubicin / Analysis
|
| 653 |
|
|
|a Surface chemistry
|
| 653 |
|
|
|a Monomolecular films / Utilization
|
| 653 |
|
|
|a Antineoplastic agents / Analysis
|
| 653 |
|
|
|a Proteins / Absorption and adsorption
|
| 653 |
|
|
|a Doxorubicin / Solubility
|
| 653 |
|
|
|a Antineoplastic Agents / analysis
|
| 653 |
|
|
|a Liposomes / Modification
|
| 653 |
|
|
|a Polyethylene glycol / Properties
|
| 653 |
|
|
|a Adenosine Deaminase / immunology
|
| 653 |
|
|
|a Polyethylene Glycols
|
| 653 |
|
|
|a Surface Properties
|
| 653 |
|
|
|a Drug carriers (Pharmacy)
|
| 653 |
|
|
|a Somatotropin / Antagonists
|
| 653 |
|
|
|a Hydrazines / analysis
|
| 653 |
|
|
|a Bioadhesive drug delivery systems
|
| 653 |
|
|
|a Human Growth Hormone / antagonists & inhibitors
|
| 653 |
|
|
|a Enzymes
|
| 653 |
|
|
|a Adenosine deaminase / Immunology
|
| 653 |
|
|
|a Enzymes / Modification
|
| 653 |
|
|
|a Oligonucleotides / Utilization
|
| 653 |
|
|
|a Prodrugs / analysis
|
| 653 |
|
|
|a Propylene oxide / Synthesis
|
| 653 |
|
|
|a Peptides / Synthesis
|
| 653 |
|
|
|a Drug Carriers
|
| 653 |
|
|
|a Polyethylene glycol / Stability
|
| 653 |
|
|
|a Block copolymers / Analysis
|
| 653 |
|
|
|a Drug Delivery Systems
|
| 653 |
|
|
|a Polyethylene glycol / Behavior
|
| 653 |
|
|
|a Polyethylene glycol / Derivatives
|
| 653 |
|
|
|a Combinatorial Chemistry Techniques
|
| 653 |
|
|
|a Coatings / Characterization
|
| 653 |
|
|
|a Polymers / chemistry
|
| 653 |
|
|
|a Cytokines / analysis
|
| 653 |
|
|
|a Prodrugs / Analysis
|
| 653 |
|
|
|a TECHNOLOGY & ENGINEERING / Chemical & Biochemical / bisacsh
|
| 700 |
1 |
|
|a Zalipsky, Samuel
|e [editor]
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Polymer Chemistry
|
| 710 |
2 |
|
|a American Chemical Society
|b Meeting ( 1997, San Francisco, California)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a "Developed from a symposium sponsored by the Division of Polymer Chemistry, Inc., at the 213th National Meeting of the American Chemical Society, San Francisco, CA, April 13-17, 1997.". - Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-1997-0680
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 668.4/234
|